Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Obituary

Robert C. Millikan: In Memoriam

A.F. Olshan, C.B. Ambrosone, J.S. Barnholtz-Sloan, M. Berwick, J. Palmer and N.E. Thomas
A.F. Olshan
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.B. Ambrosone
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.S. Barnholtz-Sloan
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Berwick
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Palmer
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.E. Thomas
1Department of Epidemiology, Gillings School of Global Public Health; 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; 3Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York; 4Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio; 5University of New Mexico Cancer Center; 6Department of Internal Medicine, University of New Mexico; Albuquerque, New Mexico; and 7Slone Epidemiology Center at Boston University, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-12-1309 Published January 2013
  • Article
  • Info & Metrics
  • PDF
Loading
Figure1

We are deeply saddened by the death of our colleague and friend, Bob Millikan. Bob passed away at the age of 55 years on October 7, 2012. Bob was a leader in the field of cancer epidemiology, especially the molecular epidemiology of breast cancer. He was a true scholar, teacher, and mentor and will be missed by many colleagues, former students, study staff, the breast cancer advocacy community, and others from the many diverse communities that had come to know and be inspired by him.

Robert C. Millikan earned undergraduate and doctoral degrees (1982 and 1984, respectively) in veterinary medicine from University of California, Davis (Davis, CA), and a Master of Public Health (1991) and Doctor of Philosophy (1993) in epidemiology from University of California, Los Angeles (Los Angeles, CA). He was a postdoctoral fellow in molecular biology at Harvard Medical School (Boston, MA) and Dana-Farber Cancer Institute (Boston, MA) and completed an internship in medicine and surgery at the School of Veterinary Medicine of the University of Pennsylvania (Philadelphia, PA; 1985). Bob joined the faculty in the Department of Epidemiology at the Gillings School of Global Public Health of the University of North Carolina (Chapel Hill, NC) in 1993. He spent the 2005 to 2006 academic year at University College Dublin (Dublin, Ireland) as a Fulbright Scholar. In 2008, he was awarded the Hulka Distinguished Professorship.

Bob was widely known for his research on breast cancer, which extended from identification of genetic and environmental etiologic risk factors to assessment of factors that impact recurrence and survival. As Principal Investigator of the Carolina Breast Cancer Study (CBCS), he greatly elucidated the etiology of specific breast cancer subtypes, particularly those that disproportionately impact African-American women. Bob's research was extremely rigorous and in-depth, but he did not stop with making important scientific discoveries. To give back to the community of women who participated in the CBCS, Bob established mechanisms for study participants to have personal contact with the investigators, and to receive information on study findings thorough annual research meetings including researchers and the community. In recent years, Bob also participated in several consortia, recognizing that it is only through collaborations and pooling of data and samples that the scientific community will be able to understand why African-American women are diagnosed with more aggressive breast cancer subtypes, are diagnosed at younger ages, and are more likely to die from the disease.

Bob's expertise in breast cancer research was also widely shared with the breast cancer advocacy community, playing a major role in educational programs. Bob was asked in 1994 by the National Breast Cancer Coalition (NBCC) to create a curriculum to teach advocates the basics of molecular biology, epidemiology, and research design. Advocates with this training would then be better prepared to engage with breast cancer scientists and survivors. This was the start of Project LEAD, a NBCC program that has graduated more than 2,000 advocates from around the world. Bob was highly regarded as a teacher, covering a wide range of topics in a highly engaging manner, always sensitive to the varying science backgrounds of the advocate students. Since his death, many advocates have paid testament to the impact Bob had on their lives and their work. Many have noted how, with his kind, quiet way, Bob not only educated them, sharing his wealth of knowledge and perspective, but also inspired them to have confidence in their participation in the advocacy and scientific communities.

Bob was also a part of the melanoma community, extending from Ireland to Italy to Denmark to Australia to Canada and throughout the United States. He was a founding member of the Genes, Environment and Melanoma (GEM), study, a large international study of melanoma risk and survival. Bob's passion for doing things correctly without need for personal recognition ranged from improving the ascertainment of melanoma in North Carolina to conducting special analyses without regard for publication on such topics as population stratification in melanoma. The GEM study meets annually and this group has met in some of Bob's favorite locations—Whistler Mountain during ski season, Copenhagen in the spring, and sunny Albuquerque, New Mexico, in the winter. Bob also greatly enjoyed his Fulbright year in Ireland studying melanoma with William Gallagher's group. He felt strongly about strengthening research ties across geographical and cultural boundaries. Bob was known for his integrity but also had a sly sense of humor that could always make you smile.

To those who knew him (this is a large cohort!), Bob will be remembered for not only his exceptional talent as a scientist, but also for being an extremely caring individual who was more interested in how you were doing than in giving a discourse on his own accomplishments. He channeled his nonwork time into many areas—coaching rowing at University of North Carolina, playing violin in a quartet, volunteering for the local Interfaith Council—all representing his world view of helping others.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (1)
January 2013
Volume 22, Issue 1
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Robert C. Millikan: In Memoriam
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Robert C. Millikan: In Memoriam
A.F. Olshan, C.B. Ambrosone, J.S. Barnholtz-Sloan, M. Berwick, J. Palmer and N.E. Thomas
Cancer Epidemiol Biomarkers Prev January 1 2013 (22) (1) 176-177; DOI: 10.1158/1055-9965.EPI-12-1309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Robert C. Millikan: In Memoriam
A.F. Olshan, C.B. Ambrosone, J.S. Barnholtz-Sloan, M. Berwick, J. Palmer and N.E. Thomas
Cancer Epidemiol Biomarkers Prev January 1 2013 (22) (1) 176-177; DOI: 10.1158/1055-9965.EPI-12-1309
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Sholom Wacholder: In Memoriam (1955–2015)
  • Brian E. Henderson: In Memoriam (1937–2015)
  • Julie A. Ross: In Memoriam (1961–2015)
Show more Obituary
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement